Clinical Trial Update: Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating pre-treatment methods for applying the QUTENZA 8% capsaicin patch; study sponsored by Astellas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Nerve Injury
• Postherpetic Neuralgia

Drugs mentioned

• QUTENZA Capsaicin 8% Patch (capsaicin patch 8%)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: or Peripheral Nerve Injury (PNI), Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) | Phase 4 | Status: COMPLETED